133 related articles for article (PubMed ID: 27640009)
1. Regioselective C-H hydroxylation of omeprazole sulfide by Bacillus megaterium CYP102A1 to produce a human metabolite.
Jang HH; Ryu SH; Le TK; Doan TT; Nguyen TH; Park KD; Yim DE; Kim DH; Kang CK; Ahn T; Kang HS; Yun CH
Biotechnol Lett; 2017 Jan; 39(1):105-112. PubMed ID: 27640009
[TBL] [Abstract][Full Text] [Related]
2. Regioselective hydroxylation of omeprazole enantiomers by bacterial CYP102A1 mutants.
Ryu SH; Park BY; Kim SY; Park SH; Jung HJ; Park M; Park KD; Ahn T; Kang HS; Yun CH
Drug Metab Dispos; 2014 Sep; 42(9):1493-7. PubMed ID: 25008345
[TBL] [Abstract][Full Text] [Related]
3. Regioselective hydroxylation of 17β-estradiol by mutants of CYP102A1 from Bacillus megaterium.
Cha GS; Ryu SH; Ahn T; Yun CH
Biotechnol Lett; 2014 Dec; 36(12):2501-6. PubMed ID: 25129047
[TBL] [Abstract][Full Text] [Related]
4. Generation of human chiral metabolites of simvastatin and lovastatin by bacterial CYP102A1 mutants.
Kim KH; Kang JY; Kim DH; Park SH; Park SH; Kim D; Park KD; Lee YJ; Jung HC; Pan JG; Ahn T; Yun CH
Drug Metab Dispos; 2011 Jan; 39(1):140-50. PubMed ID: 20962060
[TBL] [Abstract][Full Text] [Related]
5. Highly regioselective hydroxylation of polydatin, a resveratrol glucoside, for one-step synthesis of astringin, a piceatannol glucoside, by P450 BM3.
Le TK; Jang HH; Nguyen HT; Doan TT; Lee GY; Park KD; Ahn T; Joung YH; Kang HS; Yun CH
Enzyme Microb Technol; 2017 Feb; 97():34-42. PubMed ID: 28010771
[TBL] [Abstract][Full Text] [Related]
6. Selective hydroxylation of highly branched fatty acids and their derivatives by CYP102A1 from Bacillus megaterium.
Budde M; Morr M; Schmid RD; Urlacher VB
Chembiochem; 2006 May; 7(5):789-94. PubMed ID: 16566047
[TBL] [Abstract][Full Text] [Related]
7. The Versatile Biocatalyst of Cytochrome P450 CYP102A1: Structure, Function, and Engineering.
Sun Y; Huang X; Osawa Y; Chen YE; Zhang H
Molecules; 2023 Jul; 28(14):. PubMed ID: 37513226
[TBL] [Abstract][Full Text] [Related]
8. Generation of the human metabolite piceatannol from the anticancer-preventive agent resveratrol by bacterial cytochrome P450 BM3.
Kim DH; Ahn T; Jung HC; Pan JG; Yun CH
Drug Metab Dispos; 2009 May; 37(5):932-6. PubMed ID: 19237510
[TBL] [Abstract][Full Text] [Related]
9. Role of residue 87 in substrate selectivity and regioselectivity of drug-metabolizing cytochrome P450 CYP102A1 M11.
Vottero E; Rea V; Lastdrager J; Honing M; Vermeulen NP; Commandeur JN
J Biol Inorg Chem; 2011 Aug; 16(6):899-912. PubMed ID: 21567268
[TBL] [Abstract][Full Text] [Related]
10. Computational redesign of cytochrome P450 CYP102A1 for highly stereoselective omeprazole hydroxylation by UniDesign.
Huang X; Sun Y; Osawa Y; Chen YE; Zhang H
J Biol Chem; 2023 Aug; 299(8):105050. PubMed ID: 37451479
[TBL] [Abstract][Full Text] [Related]
11. The full-length cytochrome P450 enzyme CYP102A1 dimerizes at its reductase domains and has flexible heme domains for efficient catalysis.
Zhang H; Yokom AL; Cheng S; Su M; Hollenberg PF; Southworth DR; Osawa Y
J Biol Chem; 2018 May; 293(20):7727-7736. PubMed ID: 29618513
[TBL] [Abstract][Full Text] [Related]
12. Generation of human metabolites of 7-ethoxycoumarin by bacterial cytochrome P450 BM3.
Kim DH; Kim KH; Kim DH; Liu KH; Jung HC; Pan JG; Yun CH
Drug Metab Dispos; 2008 Nov; 36(11):2166-70. PubMed ID: 18669587
[TBL] [Abstract][Full Text] [Related]
13. Stereoselective hydroxylation of isophorone by variants of the cytochromes P450 CYP102A1 and CYP101A1.
Dezvarei S; Lee JHZ; Bell SG
Enzyme Microb Technol; 2018 Apr; 111():29-37. PubMed ID: 29421034
[TBL] [Abstract][Full Text] [Related]
14. Enzymatic Production of 3-OH Phlorizin, a Possible Bioactive Polyphenol from Apples, by
Nguyen NA; Cao NT; Nguyen THH; Ji JH; Cha GS; Kang HS; Yun CH
Antioxidants (Basel); 2021 Aug; 10(8):. PubMed ID: 34439575
[TBL] [Abstract][Full Text] [Related]
15. Bacillus megaterium CYP102A1 oxidation of acyl homoserine lactones and acyl homoserines.
Chowdhary PK; Keshavan N; Nguyen HQ; Peterson JA; González JE; Haines DC
Biochemistry; 2007 Dec; 46(50):14429-37. PubMed ID: 18020460
[TBL] [Abstract][Full Text] [Related]
16. The bacterial P450 BM3: a prototype for a biocatalyst with human P450 activities.
Yun CH; Kim KH; Kim DH; Jung HC; Pan JG
Trends Biotechnol; 2007 Jul; 25(7):289-98. PubMed ID: 17532492
[TBL] [Abstract][Full Text] [Related]
17. Filling a hole in cytochrome P450 BM3 improves substrate binding and catalytic efficiency.
Huang WC; Westlake AC; Maréchal JD; Joyce MG; Moody PC; Roberts GC
J Mol Biol; 2007 Oct; 373(3):633-51. PubMed ID: 17868686
[TBL] [Abstract][Full Text] [Related]
18. Semirational Protein Engineering of CYP153AM.aq. -CPRBM3 for Efficient Terminal Hydroxylation of Short- to Long-Chain Fatty Acids.
Notonier S; Gricman Ł; Pleiss J; Hauer B
Chembiochem; 2016 Aug; 17(16):1550-7. PubMed ID: 27251775
[TBL] [Abstract][Full Text] [Related]
19. Active site substitution A82W improves the regioselectivity of steroid hydroxylation by cytochrome P450 BM3 mutants as rationalized by spin relaxation nuclear magnetic resonance studies.
Rea V; Kolkman AJ; Vottero E; Stronks EJ; Ampt KA; Honing M; Vermeulen NP; Wijmenga SS; Commandeur JN
Biochemistry; 2012 Jan; 51(3):750-60. PubMed ID: 22208729
[TBL] [Abstract][Full Text] [Related]
20. Process development for the production of 15β-hydroxycyproterone acetate using Bacillus megaterium expressing CYP106A2 as whole-cell biocatalyst.
Kiss FM; Lundemo MT; Zapp J; Woodley JM; Bernhardt R
Microb Cell Fact; 2015 Mar; 14():28. PubMed ID: 25890176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
